HIV-1 protease inhibitors (Janssen/University of Southampton/Lund University)

N/A

Report date: 2025/03/20 15:47:34
NME

Base Information

Drug NameHIV-1 protease inhibitors (Janssen/University of Southampton/Lund University)
Drug Alias Namedarunavir analogs (Janssen/University of Southampton/Lund University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumSwedenUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceutica NV
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceutica NVUniversity Of SouthamptonLund University
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A